Last Updated:
Searching
Create account to add to watchlist!

Figure Acquisition Corp. I - FACA

  • Commons

    $9.90

    +0.50%

    FACA Vol: 6.0K

  • Warrants

    $1.22

    +0.83%

    FACA+ Vol: 2.2K

  • Units

    $10.37

    +2.37%

    FACA= Vol: 701.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 284.6M
Average Volume: 26.6K
52W Range: $9.63 - $10.55
Weekly %: +0.30%
Monthly %: +0.00%
Inst Owners: 3

Info

Target: Searching
Days Since IPO: 290
Unit composition:
Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one-third of one redeemable warrant
Trust Size: 25000000.0M

🕵Stocktwit Mentions

proteinlessGAINS posted at 2021-12-01T18:52:25Z

@Riceter Thanks for bringing more to my $FACA board!! I created it at #1 and now we have 18 👀. So stoked on all of this.

proteinlessGAINS posted at 2021-12-01T18:51:48Z

$FACA Say it louder for those in the back!

Riceter posted at 2021-12-01T16:55:29Z

$WTRH Remember how Waitr invested in Mike Cagney's Figure Technologies ( which will one day be taken public via $FACA ) and said they would be utilizing Figure Pay that runs on blockchain? How does same day payouts for 1099 contract drivers and debit cards and buy now pay later loans sound? What if this same technology was used for merchants such as the 26,000+ restaurants that Waitr delivers from? Blockchain rails is coming. Buy now pay later is coming. Debit cards is coming. Merchant loans is coming. This is just SOME of the suite of products and new verticals Carl has been building for his ecosystem. They are also working with UMB ( $UMBF ). If you took the time to read my entire post, here's the reward, Figure Pay for Waitr's fleet of 1099 drivers is launching now: https://drivers.deliverylogistics.io/faqfigurepay

risenhoover posted at 2021-11-30T11:07:13Z

$FACA / Figure Acquisition I files form 8-K/A - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A (Amendment No. 2) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 29, 20 https://fintel.io/sf/us/faca?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

Newsfilter posted at 2021-11-30T11:06:44Z

$FACA Form 8-K/A (current report, item 9.01) filed with the SEC https://newsfilter.io/a/927cf92269c05da77fd136ea379aa60f

proteinlessGAINS posted at 2021-11-29T15:39:06Z

@FatherJones @letsgoBrowns @proteinlessGAINS @j_investor2006 Look at $MQ too... although I also hold $KPLT, $SOFI, and $FACA as well. I sold $GSKY after merger announced, but also a contender in the #BNPL space. Good luck to all!!

proteinlessGAINS posted at 2021-11-25T01:26:29Z

@ekdi Mine: - $AFRM - $MQ - $FACA - $KPLT - $SOFI

Quantisnow posted at 2021-11-22T22:41:06Z

$FACA 📜 Figure Acquisition Corp. I filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review https://quantisnow.com/insight/2043311?s=s 45 seconds delayed.

Last10K posted at 2021-11-22T22:30:11Z

$FACA just filed with the SEC a Interim Review https://last10k.com/sec-filings/faca/0001140361-21-038948.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=faca

fla posted at 2021-11-22T22:18:43Z

$FACA [15s. delayed] filed form 8-K on November 22, 17:17:16 https://s.flashalert.me/INt0b0

risenhoover posted at 2021-11-22T22:18:39Z

$FACA / Figure Acquisition I files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2021 FIGURE ACQUISITIO https://fintel.io/sf/us/faca?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

Newsfilter posted at 2021-11-22T22:18:18Z

$FACA Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review. Figure Acquisition Corp. I previously presented a portion of its shares of.. https://newsfilter.io/a/c63bdc76462b60c6e6dcaf258bc5e7f9

Last10K posted at 2021-11-22T22:07:07Z

$FACA just filed a 10-Q Quarterly Report with 40 sections and 4 exhibits. Access them all or just read their earnings: https://last10k.com/sec-filings/faca/0001140361-21-038929.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=10KQ2040F&utm_term=faca

risenhoover posted at 2021-11-22T22:05:26Z

$FACA / Figure Acquisition I files form 10-Q https://fintel.io/sf/us/faca?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

Quantisnow posted at 2021-11-22T22:04:56Z

$FACA 📜 SEC Form 10-Q filed by Figure Acquisition Corp. I https://quantisnow.com/insight/2043176?s=s 45 seconds delayed.

fla posted at 2021-11-22T22:04:39Z

$FACA [15s. delayed] filed form 10-Q on November 22, 17:03:10 https://s.flashalert.me/AnmfP

Newsfilter posted at 2021-11-22T22:04:06Z

$FACA Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC https://newsfilter.io/a/3fddb5ea68a86c730f7fe1ba935683c1

proteinlessGAINS posted at 2021-11-16T23:03:35Z

$FACA Sooo much red on my watchlist, but Figure is pushing through with green. Nice!

Quantisnow posted at 2021-11-15T20:26:23Z

$FACA 📜 SEC Form NT 10-Q filed by Figure Acquisition Corp. I https://quantisnow.com/insight/2009587?s=s 45 seconds delayed.

risenhoover posted at 2021-11-15T20:26:08Z

$FACA / Figure Acquisition I files form NT 10-Q https://fintel.io/sf/us/faca?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

Newsfilter posted at 2021-11-15T20:25:37Z

$FACA Form NT 10-Q (notification of inability to timely file form 10-q or 10-qsb) filed with the SEC https://newsfilter.io/a/e0af01b14849635aa3ca122211a979da

proteinlessGAINS posted at 2021-11-15T00:17:17Z

$FACA 👀 12 👀

proteinlessGAINS posted at 2021-11-14T23:46:28Z

Didn't realize all $SOFI in connections the $FACA team. I'm patiently waiting for Figure to expand into all states.

proteinlessGAINS posted at 2021-11-11T13:07:26Z

@rodolfommo Nah, I want to see $FACA up and running FigurePay first.

Tickstocks posted at 2021-11-10T00:20:54Z

$FACA Tweet Stats Today's Change 3% + 🚀 https://t8sk.com/FACA

ProudWaitrBagHolder posted at 2021-11-08T16:34:16Z

$WTRH When is $FACA going IPO? So our investment into the company can start paying us back

Tickstocks posted at 2021-11-05T10:25:23Z

$FACA Tweet Stats Today's Change 3% + 🚀 https://t8sk.com/FACA

svendb7 posted at 2021-11-03T23:08:25Z

$FACA 🤫🤫

proteinlessGAINS posted at 2021-10-28T20:22:28Z

$FACA 👀 5 👀

proteinlessGAINS posted at 2021-10-28T00:35:38Z

@svendb7 They added $FACA for me!

Management

Officers and Directors.” We may engage one or more of our underwriters or one of their respective affiliates to provide additional services to us after this offering, which may include acting as financial advisor in connection with an initial business combination or as placement agent in connection with a related financing transaction. Our underwriters are entitled to receive deferred commissions that will be released from the trust only on a completion of an initial business combination. These financial incentives may cause them to have potential conflicts of interest in rendering any such additional services to us after this offering, including, for example, in connection with the sourcing and consummation of an initial business combination. We may engage one or more of our underwriters or one of their respective affiliates to provide additional services to us after this offering, including, for example, identifying potential targets, providing financial advisory services, acting as a placement agent in a private offering or arranging debt financing. We may pay such underwriter or its affiliate fair and reasonable fees or other compensation that would be determined at that time in an arm's length negotiation; provided that no agreement will be entered into with any of the underwriters or their respective affiliates and no fees or other compensation for such services will be paid to any of the underwriters or their respective affiliates prior to the date that is 60 days from the date of this prospectus, unless such payment would not be deemed underwriters' compensation in connection with this offering. The underwriters are also entitled to receive deferred commissions that are conditioned on the completion of an initial business combination. The underwriters’ or their respective affiliates’ financial interests tied to the consummation of a business combination transaction may give rise to potential conflicts of interest in providing any such additional services to us, including potential conflicts of interest in connection with the sourcing and consummation of an initial business combination. Certain of our officers and directors are now, and all of them may in the future become, affiliated with entities engaged in business activities similar to those intended to be conducted by us and, accordingly, may have conflicts of interest in allocating their time and determining to which entity a particular business opportunity should be presented. Following the completion of this offering and until we consummate our initial business combination, we intend to engage in the business of identifying and combining with one or more businesses. Our officers and directors are, and may in the future become, affiliated with entities (such as operating companies or investment vehicles) that are engaged in a similar business. There could be overlap between companies that would be suitable for a business combination with us and companies that present an attractive investment opportunity for our directors or officers, and entities with which they currently are or may in the future be affiliated. For example, our officers and several of our directors are associated with Figure, which conducts investing and related activities in our target industry. Our officers and directors also may become aware of business opportunities which may be appropriate for presentation to us and other entities to which they owe certain fiduciary or contractual duties. Any such opportunities may present additional conflicts of interest in pursuing an acquisition target, and our directors and officers may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential target business may be presented to another entity prior to its presentation to us. Our amended and restated certificate of incorporation provides that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to us without violating another legal obligation. For a complete discussion of our officers’ and directors’ business affiliations and the potential conflicts of interest that you should be aware of, please see the sections of this prospectus entitled “Management-Officers and Directors,” “Management-Conflicts of Interest” and “Certain Relationships and Related Party Transactions.” Our officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests. We have not adopted a policy that expressly prohibits our directors, officers, security holders or affiliates from having a direct or indirect pecuniary or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into an initial business combination with a target business that is affiliated with our sponsor, our directors or officers, although we do not intend to do so. We do not have a policy that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours. 69 Table of Contents Risks Relating to our Securities You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. To liquidate your investment, therefore, you may be forced to sell your public shares or warrants, potentially at a loss. Our public stockholders will be entitled to receive funds from the trust account only upon the earliest to occur of: (i) our completion of an initial business combination, and then only in connection with those shares of Class A common stock that such stockholder properly elected to redeem, subject to the limitations described herein, (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to amend our amended and restated certificate of incorporation (A) to modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of this offering or (B) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity and (iii) the redemption of our public shares if we do not complete an initial business combination within 24 months from the closing of this offering or during any Extension Period, subject to applicable law and as further described herein. In no other circumstances will a public stockholder have any right or interest of any kind in the trust account. Holders of warrants will not have any right to the proceeds held in the trust account with respect to the warrants. Accordingly, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss. The NYSE may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. We have applied to list our units for trading on the NYSE. Following the date the shares of our Class A common stock and warrants are eligible to trade separately, we anticipate that the shares of our Class A common stock and warrants will be separately listed on the NYSE. Although after giving effect to this offering we expect to meet the minimum initial listing standards set forth in the NYSE listing standards, we cannot assure you that our securities will continue to be listed on the NYSE in the future or prior to our initial business combination. In order to continue listing our securities on the NYSE prior to our initial business combination, we must maintain certain financial, distribution and stock price levels. In general, we must maintain a minimum amount in stockholders’ equity (generally $2,500,000) and a minimum of 300 public holders. Additionally, in connection with our initial business combination, we will be required to demonstrate compliance with the NYSE’s initial listing requirements, which are more rigorous than the NYSE’s continued listing requirements, in order to continue to maintain the listing of our securities on the NYSE. For instance, our stock price would generally be required to be at least $4.00 per share, our stockholders’ equity would generally be required to be at least $5,000,000 and we would be required to have a minimum of 300 round-lot holders of our unrestricted securities (with at least 50% of such round-lot holders holding unrestricted securities with a market value of at least $2,500). We cannot assure you that we will be able to meet those initial listing requirements at that time. If the NYSE delists any of our securities from trading on its exchange and we are not able to list such securities on another national securities exchange, we expect such securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including: •a limited availability of market quotations for our securities; •reduced liquidity for our securities; •a determination that our Class A common stock is a “penny stock” which will require brokers trading in our Class A common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; •a limited amount of news and analyst coverage; and •a decreased ability to issue additional securities or obtain additional financing in the future. The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” Because our units are, and we expect that eventually our Class A common stock and warrants will be, listed on the NYSE, our units, Class A common stock and warrants will be covered securities. Although the states are preempted from regulating the sale of our securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. While we are not aware of a state having used these powers to prohibit or restrict the sale of 70 Table of Contents securities issued by blank check companies, other than the State of Idaho, certain state securities regulators view blank check companies unfavorably and might use these powers, or threaten to use these powers, to hinder the sale of securities of blank check companies in their states. Further, if we were no longer listed on the NYSE, our securities would not be covered securities and we would be subject to regulation in each state in which we offer our securities, including in connection with our initial business combination. Our sponsor paid an aggregate of $25,000 in exchange for 3,194,444 shares of Class B common stock and 9,126,984 shares of Class L common stock, and, accordingly, you will experience immediate and substantial dilution from your purchase of our Class A common stock. The difference between the public offering price per share (allocating all of the unit purchase price to the Class A common stock and none to the fraction of a warrant included in the unit) and the pro forma net tangible book value per share of our Class A common stock after this offering constitutes the dilution to you and the other investors in this offering. Our sponsor acquired the shares of Class B and Class L common stock at a nominal price, significantly contributing to this dilution. Upon the closing of this offering, and assuming no value is attributed to the warrants included in the units we are offering pursuant to this prospectus or the private placement warrants, you and the other public stockholders will incur an immediate and substantial dilution of approximately 95.8% (or $9.58 per share, assuming no exercise of the underwriter’s over-allotment option), the difference between the pro forma net tangible book value per share of $0.42 and the initial offering price of $10.00 per unit. In addition, because of the anti-dilution rights of the Class B common stock, any equity or equity-linked securities issued or deemed issued in connection with our initial business combination would be disproportionately dilutive to our Class A common stock. We may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of at least 50% of the then outstanding public warrants. As a result, the exercise price of your warrants could be increased, the exercise period could be shortened and the number of shares of our Class A common stock purchasable upon exercise of a warrant could be decreased, all without your approval. Our warrants will be issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 50% of the then outstanding public warrants to make any change that adversely affects the interests of the registered holders of public warrants. Accordingly, we may amend the terms of the public warrants in a manner adverse to a holder if holders of at least 50% of the then outstanding public warrants approve of such amendment. Although our ability to amend the terms of the public warrants with the consent of at least 50% of the then outstanding public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into cash or stock, shorten the exercise period or decrease the number of shares of our Class A common stock purchasable upon exercise of a warrant. Our warrant agreement will designate the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes with our company. Our warrant agreement provides that, subject to applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and (ii) that we irrevocably submit to such jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing, these provisions of the warrant agreement will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. Any person or entity purchasing or otherwise acquiring any interest in any of our warrants shall be deemed to have notice of and to have consented to the forum provisions in our warrant agreement. If any action, the subject matter of which is within the scope of the forum provisions of our warrant agreement, is filed in a court other than a court of the State of New York or the United States District Court for the Southern District of New York (a “foreign action”) in the name of any holder of our 71 Table of Contents warrants, such holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located in the State of New York in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s counsel in the foreign action as agent for such warrant holder. This choice-of-forum provision may limit a warrant holder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with our company, which may discourage such lawsuits. Alternatively, if a court were to find this provision of our warrant agreement inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations and result in a diversion of the time and resources of our management and board of directors. A provision of our warrant agreement may make it more difficult for us to consummate an initial business combination. If: (i) we issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at a Newly Issued Price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by our board of directors and, (i) in the case of any such issuance to our sponsor or any of its affiliates, without taking into account any founder shares or shares of Class L common stock held by our sponsor or its affiliates, as applicable, prior to such issuance, and (ii) to the extent that such issuance is made to our sponsor or any of its respective affiliates, without taking into account the transfer of founder shares or private placement warrants (including if such transfer is effectuated as a surrender to us and subsequent reissuance by us) by our sponsor in connection with such issuance); (ii) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of our initial business combination (net of redemptions); and (iii) the Market Value is below $9.20 per share, then the exercise price of the warrants will be adjusted to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger prices described under “Description of Securities-Redeemable Warrants-Public Stockholders’ Warrants-Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described under “Description of Securities-Redeemable Warrants-Public Stockholders’ Warrants-Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. This may make it more difficult for us to consummate an initial business combination with a target business.

Holder Stats

1 0
% of Shares Held by All Insider 0.00%
% of Shares Held by Institutions 0.01%
% of Float Held by Institutions 0.01%
Number of Institutions Holding Shares 3

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2021-11-15 Marshall Wace LLP 804,469 $7,920,000 0.0% 0 1.959%
2021-08-13 Oribel Capital Management LP 314,033 $3,150,000 0.2% -0.6% 0.765%
2021-08-13 RP Investment Advisors LP 577,160 $5,770,000 0.8% +930.2% 1.405%
2021-08-11 Picton Mahoney Asset Management 175,000 $1,760,000 0.1% 0 0.426%
2021-07-28 Cohen & Co Financial Management LLC 500,000 $5,000,000 3.2% 0 1.217%

SEC Filings

Form Type Form Description Filing Date Document Link
8-K/A 8-K/A 2021-11-30 https://www.sec.gov/Archives/edgar/data/1839550/000114036121039732/brhc10031126_8ka.htm
8-K 8-K 2021-11-22 https://www.sec.gov/Archives/edgar/data/1839550/000114036121038948/brhc10031038_8k.htm
10-Q 10-Q 2021-11-22 https://www.sec.gov/Archives/edgar/data/1839550/000114036121038929/brhc10030502_10q.htm
NT 10-Q NT 10-Q 2021-11-15 https://www.sec.gov/Archives/edgar/data/1839550/000114036121037868/brhc10030845_nt10q.htm
10-Q 10-Q 2021-08-13 https://www.sec.gov/Archives/edgar/data/1839550/000114036121028271/brhc10027759_10q.htm
8-K/A 8-K/A 2021-06-04 https://www.sec.gov/Archives/edgar/data/1839550/000114036121019921/brhc10025495_8ka.htm
10-Q 10-Q 2021-05-24 https://www.sec.gov/Archives/edgar/data/1839550/000114036121018565/brhc10024893_10q.htm
8-K 8-K 2021-05-24 https://www.sec.gov/Archives/edgar/data/1839550/000114036121018520/brhc10025012_8k.htm
NT 10-Q FORM NT 10-Q 2021-05-17 https://www.sec.gov/Archives/edgar/data/1839550/000095010321007341/dp151114_nt10q.htm
8-K FORM 8-K 2021-04-07 https://www.sec.gov/Archives/edgar/data/1839550/000095010321005329/dp149137_8k.htm
8-K FORM 8-K 2021-03-01 https://www.sec.gov/Archives/edgar/data/1839550/000095010321003269/dp147050_8k.htm
8-K FORM 8-K 2021-02-24 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002918/dp146720_8k.htm
4 FORM 4 2021-02-24 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002861/xslF345X03/dp146721_4-fintech.xml
4 FORM 4 2021-02-24 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002854/xslF345X03/dp146722_4-davies.xml
424B4 FORM 424B4 2021-02-22 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002699/dp146494_424b4.htm
3 FORM 3 2021-02-19 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002596/xslF345X02/dp146449_3-fintech.xml
3 FORM 3 2021-02-19 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002587/xslF345X02/dp164390_3-hirji.xml
3 FORM 3 2021-02-19 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002566/xslF345X02/dp146389_3-davies.xml
3 FORM 3 2021-02-19 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002565/xslF345X02/dp146387_3-nazareth.xml
3 FORM 3 2021-02-19 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002564/xslF345X02/dp146388_3-miller.xml
3 FORM 3 2021-02-19 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002563/xslF345X02/dp146386_3-chao.xml
EFFECT 2021-02-18 https://www.sec.gov/Archives/edgar/data/1839550/999999999521000689/xslEFFECTX01/primary_doc.xml
CERT NYSE CERTIFICATION 2021-02-17 https://www.sec.gov/Archives/edgar/data/1839550/000087666121000235/FACA021721.pdf
8-A12B FORM 8-A12B 2021-02-17 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002411/dp146275_8a12b.htm
CORRESP 2021-02-17 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002408/filename1.htm
CORRESP 2021-02-17 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002407/filename1.htm
CORRESP 2021-02-11 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002150/filename1.htm
S-1/A FORM S-1/A 2021-02-11 https://www.sec.gov/Archives/edgar/data/1839550/000095010321002149/dp145987_s1a.htm
UPLOAD 2021-02-08 https://www.sec.gov/Archives/edgar/data/1839550/000000000021001551/filename1.pdf
CORRESP 2021-02-03 https://www.sec.gov/Archives/edgar/data/1839550/000095010321001741/filename1.htm
S-1 FORM S-1 2021-02-03 https://www.sec.gov/Archives/edgar/data/1839550/000095010321001739/dp145243_s1.htm
UPLOAD 2021-02-02 https://www.sec.gov/Archives/edgar/data/1839550/000000000021001341/filename1.pdf
DRS 2021-01-12 https://www.sec.gov/Archives/edgar/data/1839550/000095010321000394/filename1.htm